Neurocrine Biosciences, Inc.
NBIX
$131.14
-$1.24-0.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 37.57% | -9.22% | -6.09% | -22.06% | 4.31% |
| Total Receivables | 43.35% | 51.32% | 27.23% | 14.49% | 9.06% |
| Inventory | 20.21% | 51.31% | 33.88% | 58.87% | 49.87% |
| Prepaid Expenses | 251.96% | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 82.08% | -43.96% | 0.42% | 18.71% | -34.97% |
| Total Current Assets | 46.27% | 15.02% | 4.74% | -8.95% | 7.32% |
|
|
|||||
| Total Current Assets | 46.27% | 15.02% | 4.74% | -8.95% | 7.32% |
| Net Property, Plant & Equipment | -7.91% | 67.86% | 70.26% | 70.24% | 70.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 3.48% | 11.04% | 6.12% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -29.37% | -23.75% | 16.99% | 19.95% | 32.31% |
| Total Assets | 24.55% | 20.67% | 17.69% | 6.20% | 14.37% |
|
|
|||||
| Total Accounts Payable | 5.01% | 25.29% | -2.43% | 26.00% | -25.06% |
| Total Accrued Expenses | 42.56% | 56.36% | 42.94% | 11.37% | 11.47% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 47.41% | 43.22% | -71.10% | -- |
| Total Finance Division Other Current Liabilities | 44.56% | 9.09% | 591.30% | -83.10% | 56.27% |
| Total Other Current Liabilities | 44.56% | 9.09% | 591.30% | -83.10% | 56.27% |
| Total Current Liabilities | 46.43% | 48.48% | 37.09% | -26.65% | -22.46% |
|
|
|||||
| Total Current Liabilities | 46.43% | 48.48% | 37.09% | -26.65% | -22.46% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.75% | 70.41% | 71.39% | 76.95% | 76.19% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 32.19% | 44.96% | 48.90% | 50.71% | 56.35% |
| Total Liabilities | 22.09% | 54.65% | 50.23% | 6.05% | 10.75% |
|
|
|||||
| Common Stock & APIC | 9.30% | 2.79% | 1.64% | 1.42% | 7.25% |
| Retained Earnings | 1,433.22% | 262.52% | 273.51% | 95.34% | 118.59% |
| Treasury Stock & Other | 125.86% | -8.97% | 400.00% | 172.73% | -17.14% |
| Total Common Equity | 25.62% | 10.47% | 7.38% | 6.27% | 16.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 25.62% | 10.47% | 7.38% | 6.27% | 16.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 25.62% | 10.47% | 7.38% | 6.27% | 16.03% |
|
|
|||||